Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Mind Cure Health Inc. (C:MCUR)

Business Focus: Biotechnology & Medical Research (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for MCUR within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jan 25, 2023 16:15 ET
MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2023
VANCOUVER, BC, Jan. 25, 2023 /CNW/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company") today announced its financial results for the three and six months ended November 30, 2022.  All amounts are stated in Canadian dollars unless otherwise indicated.  
Read full article
Jan 25, 2023 16:15 ET
MINDCURE Announces Financial Results for the Second Quarter of Fiscal 2023
VANCOUVER, BC, Jan. 25, 2023 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company") today announced its financial results for the three and six months ended November 30, 2022.  All amounts are stated in Canadian dollars unless otherwise indicated.  
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
--
6.71
4.80
Price to Book - most recent quarter
1.10
2.08
1.75
Price to Cash Flow per share - TTM
--
13.34
9.75
Price to Free Cash Flow per share - TTM
--
33.56
13.11
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jan 15, 202320,7060
Dec 31, 202220,7060
Dec 15, 202220,7060
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Mind Cure Health Inc. is a life sciences company. The Company is engaged in identifying, developing, and commercializing products for mental health and wellness. Its digital platform, iSTRYM, which provides psychedelic therapy software. It is a software application designed to provide data-driven support and optimize therapeutic outcomes. iSTRYM offers clinicians global, data-proofed protocols and integration plans, insights into client journeys, and real-time assessments for personalized care. Its research programs include Desire Project and Ibogaine Project. Its Desire Project is a clinical research program focused on the treatment of female hypoactive sexual desire disorder (HSDD). It develops solution using pharmaceutical Methylenedioxymethamphetamine (MDMA) and psychotherapy to treat HSDD. Its Ibogaine Project has developed non-racemic mixtures of ibogaine in the MC-808 program for the treatment of psychiatric and neurological central nervous system (CNS) disorders.

See business summary

 

Twitter

Search (past week) for $MCUR.CA

  • No tweets found